Cleared Traditional

K831079 - LIQUIPETTE

K831079 is an FDA 510(k) clearance for LIQUIPETTE, manufactured by The Kendall Company Div. of Tyco Healthcare Group. The device is a Class 1 Hematology device with product code GJG cleared through the Traditional 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1983
Decision
24d
Days
Class 1
Risk

K831079 is an FDA 510(k) clearance for the LIQUIPETTE. Classified as Pipette, Quantitative, Hematology (product code GJG), Class I - General Controls.

Submitted by The Kendall Company Div. of Tyco Healthcare Group (Mchenry, US). The FDA issued a Cleared decision on April 28, 1983 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.6160 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Kendall Company Div. of Tyco Healthcare Group devices

FDA 510(k) Submission Details - K831079

510(k) Number K831079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 1983
Decision Date April 28, 1983
Days to Decision 24 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 113d · This submission: 24d
Pathway characteristics
Predicate-based equivalence.

GJG Device Classification - Class 1, General Controls

Product Code GJG Pipette, Quantitative, Hematology
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.6160
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.